Dr. R. Wade McKenna to Speak on Stem Cell Therapy at T-POC & Newclip Technics 2013 Event
Dr. R. Wade McKenna, will share his expertise in stem cell therapy during the 2013 Dinner Event for The Progressive Orthopedic Company (T-POC) and Newclip Technics USA. The event will be held Friday, March 22 in Chicago, Illinois during the American Academy of Orthopaedic Surgeons 2013 Annual Meeting.
Ocala, FL, March 14, 2013 --(PR.com)-- Biologic Therapies (www.biologictherapies.com), a medical device company specializing in the design and manufacturing of proprietary medical components for the autologous orthobiologic stem cell therapy / regenerative medicine market, has announced its Chief Medical Director, Dr. R. Wade McKenna, will share his expertise in stem cell therapy during the 2013 Dinner Event for The Progressive Orthopedic Company (T-POC) and Newclip Technics USA. The event will be held Friday, March 22 in Chicago, Illinois during the American Academy of Orthopaedic Surgeons 2013 Annual Meeting. Dr. McKenna’s speech will be entitled, ‘The Clinical Use and Theory of Bone Marrow Aspirate Concentrate.’
A leading advocate of autologous orthobiologic stem cell therapy and regenerative medicine, Dr. McKenna is focused on advancing the clinical benefits in orthopedics. Board certified in orthopedic surgery, Dr. McKenna is a co-founder of Biologic Therapies. His achievements include the recent development of the company’s Bio-MAC Bone Marrow Aspiration Catheter, treating world-class athletes and developing numerous surgical and non-surgical stem cell application protocols.
Dr. McKenna is Fellowship trained in Trauma and Post Traumatic Reconstruction, specializing in Sports Medicine and Autologous Biologics. Noted for his expertise and innovative procedures, Dr. McKenna says, “I’m honored to share my knowledge of autologous orthobiologic stem cell therapy with an esteemed international audience. I’m also looking forward to hearing how this extraordinarily important form of regenerative medicine is progressing around the world.”
Producing positive clinical outcomes augmented by concentrated, autologous bone marrow aspirate is Dr. McKenna’s passion. This stem cell enriched product has been applied to over 1500 successful surgical and non-surgical cases. Applications include long bone non-unions, avascular necrosis of the femoral head, severe clavicle non-unions, cartilage regeneration, chondrogenesis and soft tissue repair of the shoulder, chronic tendonopathy, tendon ruptures as well as numerous applications to common, often difficult foot & ankle injuries and wrists fractures.
Dr. McKenna earned his undergraduate degree and medical degree at Oklahoma State University. He then completed his orthopedic residency at the Dallas/Fort Worth Medical Center and his trauma fellowship at Tampa General Hospital. With over 20 years in private practice, Dr. McKenna has successfully built McKenna Orthopedics in Trophy Club, Texas as well as, North Central Texas Orthopedics & Sports Medicine in Decatur, Texas. Dr. McKenna is licensed to practice medicine in Texas and Florida.
About Biologic Therapies
Based in Ocala, Florida, Biologic Therapies, Inc. (BTI) is a company with a principal strategy of seeking out and developing innovative, proprietary and patented technologies to meet the needs of the emerging autologous orthobiologic market. BTI’s mission is to provide proprietary, groundbreaking medical technologies that significantly enhance the body’s natural healing ability, providing patients with improved outcomes and quicker restoration of function. The Company’s initial focus and products provide extended access to this market within the well-established orthopedic medical device market.
For more information contact Scott Reynolds, Biologic Therapies’ Vice President Marketing, at 352-304-5149.
A leading advocate of autologous orthobiologic stem cell therapy and regenerative medicine, Dr. McKenna is focused on advancing the clinical benefits in orthopedics. Board certified in orthopedic surgery, Dr. McKenna is a co-founder of Biologic Therapies. His achievements include the recent development of the company’s Bio-MAC Bone Marrow Aspiration Catheter, treating world-class athletes and developing numerous surgical and non-surgical stem cell application protocols.
Dr. McKenna is Fellowship trained in Trauma and Post Traumatic Reconstruction, specializing in Sports Medicine and Autologous Biologics. Noted for his expertise and innovative procedures, Dr. McKenna says, “I’m honored to share my knowledge of autologous orthobiologic stem cell therapy with an esteemed international audience. I’m also looking forward to hearing how this extraordinarily important form of regenerative medicine is progressing around the world.”
Producing positive clinical outcomes augmented by concentrated, autologous bone marrow aspirate is Dr. McKenna’s passion. This stem cell enriched product has been applied to over 1500 successful surgical and non-surgical cases. Applications include long bone non-unions, avascular necrosis of the femoral head, severe clavicle non-unions, cartilage regeneration, chondrogenesis and soft tissue repair of the shoulder, chronic tendonopathy, tendon ruptures as well as numerous applications to common, often difficult foot & ankle injuries and wrists fractures.
Dr. McKenna earned his undergraduate degree and medical degree at Oklahoma State University. He then completed his orthopedic residency at the Dallas/Fort Worth Medical Center and his trauma fellowship at Tampa General Hospital. With over 20 years in private practice, Dr. McKenna has successfully built McKenna Orthopedics in Trophy Club, Texas as well as, North Central Texas Orthopedics & Sports Medicine in Decatur, Texas. Dr. McKenna is licensed to practice medicine in Texas and Florida.
About Biologic Therapies
Based in Ocala, Florida, Biologic Therapies, Inc. (BTI) is a company with a principal strategy of seeking out and developing innovative, proprietary and patented technologies to meet the needs of the emerging autologous orthobiologic market. BTI’s mission is to provide proprietary, groundbreaking medical technologies that significantly enhance the body’s natural healing ability, providing patients with improved outcomes and quicker restoration of function. The Company’s initial focus and products provide extended access to this market within the well-established orthopedic medical device market.
For more information contact Scott Reynolds, Biologic Therapies’ Vice President Marketing, at 352-304-5149.
Contact
Biologic Therapies
Scott Reynolds
352-304-5149
www.BiologicTherapies.com
Scott Reynolds
352-304-5149
www.BiologicTherapies.com
Contact
Categories